Jedd Wolchok, MD
Enriched profileSandra and Edward Meyer Director, Sandra and Edward Meyer Cancer Center; Professor of Medicine · Weill Cornell Medicine
Jedd Wolchok is Sandra and Edward Meyer Director, Sandra and Edward Meyer Cancer Center; Professor of Medicine at Weill Cornell Medicine. OpenAlex indexes 1,448 publications with 208,418 citations (h-index 176); ClinicalTrials.gov lists 10 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Medical Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Jedd Wolchok, MD, is Sandra and Edward Meyer Director, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. The public record shows 1,448 publications with 208,418 citations (h-index 176), centered on Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 7 companies, 7 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2026 · The Journal of experimental medicine
- Top research focus: Cancer Immunotherapy and Biomarkers
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 60 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 551.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors
Sponsor: Memorial Sloan Kettering Cancer Center
- A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab
Sponsor: Ludwig Institute for Cancer Research
- Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma
Sponsor: Ludwig Institute for Cancer Research
Industry payments
Updated 14 Oct 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Astellas Pharma US IncProgram year20253 payments
- TAIHO ONCOLOGY, INC.Program year20251 payment
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Kinase inhibitor100%Mekinist50%Tafinlar50%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
7 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- Identifying targets to mitigate immunotherapy-associated immune-related adverse events
Weill Medical Coll of Cornell Univ
FY2026$703,423R01CA306020 - Determining the role of neutrophils in anti-tumor immunity and immune-related adverse events in the context of T cell-based therapies
Weill Medical Coll of Cornell Univ
FY2026$685,737R01CA297338 - Determining the role of neutrophils in anti-tumor immunity and immune-related adverse events in the context of T cell-based therapies
Weill Medical Coll of Cornell Univ
FY2025$702,748R01CA297338
Congress activity
Updated 14 Oct 2026
228 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Abstract 5624: Clinical strategies to enhance the efficacy of tumor-infiltrating lymphocyte (TIL) therapy using preclinical models
AACR Annual Meeting
AACR2026Co-author - Abstract 6537: Tumor IDO1 drives resistance to adoptive cell transfer by suppressing T cell recruitment and effector function
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.
The Journal of experimental medicine
Article2026 - Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery.
Journal of clinical oncology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Improved Survival with Ipilimumab in Patients with Metastatic Melanoma15,164 citations2010
- 02Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma8,158 citations2015
- 03
- 04Cancer immunotherapy using checkpoint blockade6,751 citations2018
- 05Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma5,396 citations2017
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jedd-wolchok-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/jedd-wolchok-a8665b6
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/lab/Jedd-D-Wolchok-Lab
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - X / Twitter
x.com/wolchokj
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/weillcornellmedicine_dr-jedd-wolchok-appointed-meyer-director-activity-6958402433865678849-DPV8
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/how-melanoma-met-its-match-cancer-immunotherapy/id1789801996
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Spotify
open.spotify.com/episode/4Xq1LBDqMikTOJ3B5wKSPe
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →open.spotify.com ↗ - X / Twitter
x.com/WeillCornell/status/1552636745031847936
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
- Board Certified
Internal Medicine (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗ - Board Certified
Medical Oncology (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →connection.asco.org ↗
- Member
Scientific Advisory Council, Cancer Research Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerresearch.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.weill.cornell.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newswise.com ↗
- Fellow
American Society of Clinical Oncology (FASCO)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aacr.org ↗ - Fellow
American Association for Cancer Research (FAACR)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗
Secondary affiliations
appointments beyond the home institution- Memorial Sloan Kettering Cancer Center
formerly Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation and Chief of Immuno-Oncology Service, prior to 2022 move to Weill Cornell
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aacr.org ↗ - Ludwig Institute for Cancer Research
Board of Directors member; Co-Director, Ludwig Collaborative Laboratory at Weill Cornell Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ludwigcancerresearch.org ↗ - NewYork-Presbyterian Hospital
Cutaneous Oncology and Melanoma Program, attending physician
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗ - Parker Institute for Cancer Immunotherapy
affiliated member/investigator
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →parkerici.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
- Feature profile
The Cancer Letter, "Weill Cornell's path to NCI designation runs through Brooklyn and Queens"
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerletter.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →open.spotify.com ↗
- Video interview
"Dr. Jedd Wolchok on Immunotherapy Toxicities", OncLive
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Profile feature
Princeton Alumni Weekly, "Jedd Wolchok '87: A Believer From the Start"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →paw.princeton.edu ↗ - Written interview
News-Medical.net, "Using the immune system to control cancer"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news-medical.net ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ronald Crystal, MD
Weill Cornell Medicine
Robert Harrington, MD
Weill Cornell Medicine
Giuseppe Giaccone, MD, PhD
Weill Cornell Medicine
Massimo Cristofanilli, MD
Weill Cornell Medicine
Mario Sznol, MD
University of Miami Miller School of Medicine
Kevin Brown, MD
National Cancer Institute
Patrick Ott, MD
Dana-Farber Cancer Institute
Udai Kammula, MD
University of Pittsburgh